ESCAPE Bio is a preclinical stage biopharmaceutical company focused on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. We are passionate about making a meaningful clinical impact for patients suffering from CNS diseases and believe in a genetically defined approach to achieving this goal.
| Website | http://www.escapebio.com/ |
| Employees | 6 (3 on RocketReach) |
| Founded | 2015 |
| Address | 4000 Shoreline Court Suite 400, South San Francisco, California 94080, US |
| Phone | +1 650-431-0100 |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Neurodegenerative Diseases, Preclinical Development, Therapeutic Development, Gene Therapy, Drug Discovery, Biotechnology, Pharmaceutical Research, Treatment Development, Genetic Diseases, New Therapies, Clinical Trials, Neurology, Clinical Stage, Molecular Medicine, Cell Therapy, Rare Diseases, Alzheimers, Parkinsons, Protein Engineering |
| Competitors | Amgen, Biogen, Vertex Pharmaceuticals, Roche, AstraZeneca, Lilly India, AbbVie, Sanofi, Regeneron, Novartis +39 more (view full list) |
Looking for a particular ESCAPE Bio employee's phone or email?
Paul Wren is the CSO of ESCAPE Bio.
3 people are employed at ESCAPE Bio.
ESCAPE Bio is based in South San Francisco, California.